全髋置换术后下肢深静脉血栓形成的风险预测
作者:
作者单位:

福建医科大学附属协和医院骨科,福建福州 350001

作者简介:

林文韬,副主任医师,研究方向:关节外科,(电子信箱)wentaolin@126.com

中图分类号:

R687.4


Risk prediction of lower extremity deep vein thrombosis after total hip arthroplasty
Author:
Affiliation:

Department of Orthopedics, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001 , China

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [16]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    [目的] 探讨全髋关节置换术(total hip arthroplasty, THA) 后下肢深静脉血栓形成(deep vain thrombosis, DVT) 的风险因素。[方法] 回顾分析本院骨科2018 年6 月—2022 年6 月364 例初次THA 患者临床资料。依据术后临床与超声检查,将患者分为DVT 组和非DVT 组,比较两组资料,行二元多因素逻辑回归分析,依据逻辑分析结果构建预测列线图。采用受试者工作特征曲线分析评价列线图的预测效能。[结果] 364 患者中,72 例患者发生DVT,占19.8%;另外292 例患者未发生DVT,占80.2%。DVT 组年龄、BMI、合并糖尿病、血栓史、手术时间、双侧置换比率和卧床时间均显著大于非DVT 组(P<0.05),但是,前者使用抗凝剂的比率显著低于后者(P<0.05)。逻辑分析表明,年龄≥70 岁(OR=4.127, 95%CI 1.712~5.392, P=0.012)、BMI≥28 kg/m2 (OR=2.916, 95% CI 1.153~4.124, P=0.063)、糖尿病(OR=2.328, 95% CI 1.412~4.411, P=0.067)、既往血栓病史(OR=5.270, 95%CI 1.091~2.559, P=0.011)、手术时间≥120 min(OR=3.541, 95%CI 1.215~4.089, P=0.027)、双侧置换(OR=2.286,95%CI 1.407~4.531, P=0.034)、术后卧床≥3 d(OR=4.427, 95%CI 1.136~1.973, P=0.023) 是DVT 发生的危险因素;而使用抗凝药物是DVT 发生的保护因素(OR=-2.019, 95%CI -1.723~-5.802, P<0.001)。逻辑分析构建列线图预测模型并验证,ROC 曲线下面积(AUC) 为0.867(95%CI 0.711~1.000)。[结论] 本研究筛选出高龄、糖尿病、血栓史、手术时间、双侧关节置换、卧床时间是全髋关节置换术后下肢深静脉血栓形成的相关因素,并构建了效果较好的列线图预测模型,可能为防治DVT 提供参考。

    Abstract:

    [Objective] To search the risk factors of deep vain thrombosis (DVT) after total hip arthroplasty (THA). [Methods] A retro-spective study was conducted on 364 patients who received initial THA in our hospital from June 2018 to June 2022. According to postopera-tive clinical and ultrasound examination, patients were divided into DVT group and non-DVT group. The data of the two groups were com-pared, and binary multi-factor logistic regression analysis was performed, and the prediction nomogram was constructed according to the re-sults of logical analysis. The predictive efficiency of the nomogram was evaluated by the receiver operating characteristic curve analysis. [Re-sults] Among 364 patients, 72 had DVT, accounting for 19.8%, whereas the other 292 patients did not develop DVT, accounting for 80.2%.The DVT group proved significantly greater than the non-DVT group in terms of age, BMI, diabetes mellitus, history of thrombosis, operationtime, bilateral replacement ratio and bed rest time (P<0.05), but the former was significantly less than the latter regarding to the ratio of anti-coagulant usage (P<0.05). As results of logical analysis, the age≥70 years (OR=4.127, 95%CI 1.712~5.392, P=0.012), BMI≥28 years (OR=2.916, 95%CI 1.153~4.124, P=0.063), diabetes mellitus (OR=2.328, 95%CI 1.412~4.411, P=0.067), previous history of thrombosis (OR=5.270, 95%CI 1.091~2.559, P=0.011), operation time ≥120 min (OR=3.541, 95%CI 1.215~4.089, P=0.027), bilateral replacement (OR=2.286, 95%CI 1.407~4.531, P=0.034), and postoperative bed rest ≥3 d (OR=4.427, 95%CI 1.136~1.973, P=0.023) were the risk factor forDVT, whereas the use of anticoagulants was a protective factor for DVT (OR=-2.019, 95%CI -1.723~-5.802, P<0.001). A nomogram predic-tion model was created based on the logical regression outcome and verified by ROC with area under curve (AUC) of 0.867 (95%CI 0.711~1.000). [Conclusion] In this study, advanced age, diabetes, previous thrombosis, operative time, bilateral joint replacement, and bed resttime were selected as the related factors for deep vein thrombosis after total hip arthroplasty, and a better predictive model was established,which may provide reference for the prevention and treatment of DVT.

    参考文献
    [1] 中华医学会骨科学分会.中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2016,36(2):65-71.DOI:10.3760/cma.j.issn.0253-2352.2016.02.001.Chinese Orthopaedic Association.Prevention of venous thromboembolism after major orthopaedic surgery [J].Chinese Journal of Orthopaedics,2016,36(2):65-71.DOI:10.3760/cma.j.issn.0253-2352.2016.02.001.
    [2] 吴煜琪,陈文月,刘臻,等.髋关节置换术后症状性静脉血栓栓塞症的发生情况及危险因素[J].临床与病理杂志,2022,42(5):1117-1122.DOI:10.3978/j.issn.2095-6959.2022.05.016.Wu YQ,Chen WY,Liu Z,et al.Occurrence and risk factors ofsymptomatic venous thromboembolism after hip arthroplasty [J].Journal of Clinical and Pathological Research,2022,42(5):1117-1122.DOI:10.3978/j.issn.2095-6959.2022.05.016.
    [3] Keller K,Hobohm L,Barco S,et al.Venous thromboembolism inpatients hospitalized for hip joint replacement surgery [J].ThrombRes,2020,190:1-7.DOI:10.1016/j.thromres.2020.03.019.
    [4] White RH,Henderson MC.Risk factors for venous thromboembolism after total hip and knee replacement surgery [J].Curr OpinPulmon Med,2002,8(5):365-371.DOI:10.1097/00063198-200209000-00004.
    [5] Jenny JY,Bulaid Y,Boisrenoult P,et al.Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip orknee replacement within an enhanced recovery program [J].Orthop Traumatol Surg Res,2020,106(8):1533-1538.DOI:10.1016/j.otsr.2020.02.026.
    [6] 尹琪楠,韩丽珠,边原,等.2021 年版《亚太膝关节和髋关节置换术和髋部骨折手术静脉血栓栓塞共识:静脉血栓栓塞症的药物预防》解读[J].医药导报,2022,41(5):599-602.DOI:10.3870/j.issn.1004-0781.2022.05.001.Yin QN,Han LZ,Bian Y,et al.Interpretation of 2021 Asia-PacificVenous Thromboembolism Consensus in Knee and Hip Arthroplasty and Hip Fracture Surgery:Pharmacological venous thromboembolism prophylaxis [J].Herald of Medicine,2022,41(5):599-602.DOI:10.3870/j.issn.1004-0781.2022.05.001.
    [7] Li Y,Shan J.Study on the correlation between high density lipoprotein and lower extremities deep venous thrombosis in patients undergoing hip arthroplasty [J].Phlebology,2022,37(7):516-521.DOI:10.1177/02683555221090309.
    [8] Fu YH,Liu P,Xu X,et al.Deep vein thrombosis in the lower extremities after femoral neck fracture:a retrospective observationalstudy [J].J Orthop Surg(Hong Kong),2020,28(1):2309499019901172.DOI:10.1177/2309499019901172.
    [9] Ghosh A,Best AJ,Rudge SJ,et al.Clinical effectiveness of aspirinas multimodal thromboprophylaxis in primary total hip and knee arthroplasty:a review of 6 078 cases [J].J Arthroplasty,2019,34(7):1359-1363.DOI:10.1016/j.arth.2019.03.021.
    [10] Wang H,Rosendaal FR,Cushman M,et al.Procoagulant factor levels and risk of venous thrombosis in the elderly [J].J Thromb Haemost,2021,19(1):186-193.DOI:10.1111/jth.15127.
    [11] Shao H,Chen C,Maltenfort MG,et al.Bilateral total hip arthroplasty:1-stage or 2-stage?A Meta-analysis [J].J Arthroplasty,2017,32(2):689-695.DOI:10.1016/j.arth.2016.09.022.
    [12] 杨玉春,汪小海,张咏梅,等.老年患者全麻下全髋置换术后下肢深静脉血栓发生情况及危险因素[J].局解手术学杂志,2019,28(2):108-111.DOI:10.11659/jjssx.09E018067.Yang YC,Wang XH,Zhang YM,et al.Incidence and risk factorsof deep venous thrombosis for the elderly patients with total hip arthroplasty under general anesthesia [J].Journal of Regional Anatomy and Operative Surgery,2019,28(2):108-111.DOI:10.11659/jjssx.09E018067.
    [13] Ferdosian S,Orellana I,Nager G,et al.Patients with body mass index ≥25 kg/m2 as a target population for improvement of rate of follow-up duplex venous ultrasound examinations following initial incomplete examinations [J].J Vasc Surg Venous Lymphat Disord,2023,11(4):774-782.e1.DOI:10.1016/j.jvsv.2023.03.013.
    [14] Wallace G,Judge A,Prieto-Alhambra D,et al.The effect of bodymass index on the risk of post-operative complications during the6 months following total hip replacement or total knee replacement surgery [J].Osteoarthritis Cartilage,2014,22(7):918-927.DOI:10.1016/j.joca.2014.04.013.
    [15] Qin W,Huang X,Yang H,et al.The influence of diabetes mellituson patients undergoing primary total lower extremity arthroplasty:asystematic review and meta-analysis [J].Biomed Res Int,2020,2020:6661691.DOI:10.1155/2020/6661691.
    [16] Vu?kovi? BA,Cannegieter SC,van Hylckama Vlieget A,et al.Recurrent venous thrombosis related to overweight and obesity:results from the MEGA follow-up study [J].J Thromb Haemost,2017,15(7):1430-1435.DOI:10.1111/jth.13710.
    引证文献
    Comments
    Comments
    分享到微博
    Submit
引用本文

林文韬,冯尔宥,姚志鹏,等. 全髋置换术后下肢深静脉血栓形成的风险预测[J]. 中国矫形外科杂志, 2024, 32 (23): 2200-2204. DOI:10.20184/j. cnki. Issn1005-8478.110251.
LIN Wen-tao, FENG Er-yu, YAO Zhi-peng, et al. Risk prediction of lower extremity deep vein thrombosis after total hip arthroplasty[J]. Orthopedic Journal of China , 2024, 32 (23): 2200-2204. DOI:10.20184/j. cnki. Issn1005-8478.110251.

复制
文章指标
  • 点击次数:80
  • 下载次数: 569
  • 引用次数: 0
历史
  • 收稿日期:March 29,2024
  • 最后修改日期:July 26,2024
  • 在线发布日期: December 04,2024